Search - tctmd.com

Displaying 981 - 1000 of 2437

Sort: Relevancy | Date

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Daily News

Differing Advice for Infective Endocarditis Surgery Stems From Evidence Gaps

Caitlin E. Cox

January 25, 2022

News Features

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

L.A. McKeown

December 20, 2021

Presentation Controversies and Advances 2021

Recent Advances in Transcatheter Tricuspid & Mitral Valve Replacement

Presenter: Raj R. Makkar

December 03, 2021

Presentation Controversies and Advances 2021

Echocardiography to Assess & Facilitate Management of MR

Presenter: Robert J. Siegel

December 03, 2021

News Daily News PCR London Valves 2021

Cardiologist Tests Positive for Omicron COVID-19 After Trip to PCR London Valves

Michael O'Riordan

December 01, 2021

News Opinion CV Team Dispatch

December 2021 News Roundup

L.A. McKeown

December 01, 2021

News Conference News PCR London Valves 2021

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

Shelley Wood

November 26, 2021

News Conference News PCR London Valves 2021

‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI

Michael O'Riordan

November 25, 2021

News Conference News PCR London Valves 2021

Promising Early Results for TriClip in Tricuspid Regurgitation: bRIGHT Registry

Shelley Wood

November 24, 2021

News Conference News AHA 2021

PALACS: Posterior Left Pericardiotomy Cuts Postop AF After Cardiac Surgery

Todd Neale

November 14, 2021

News Conference News AHA 2021

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

Caitlin E. Cox

November 13, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

Presentation TCT 2021

EXPAND G4: Core Laboratory Echocardiographic Outcomes From a Multicenter Study of a Fourth Generation TEER System to Treat Mitral Regurgitation

Presenter: Evelio Rodriguez

November 06, 2021

Presentation TCT 2021

Expanding Treatable Anatomies with TMVR

Presenter: Scott Lim

November 06, 2021

Presentation TCT 2021

Intrepid TA Data Review and Program Update

Presenter: Martin Leon

November 06, 2021

News Conference News TCT 2021

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

Yael L. Maxwell

November 06, 2021

Presentation TCT 2021

Intrepid TMVR Early Feasibility: Thirty-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement

Presenter: Firas Zahr

November 06, 2021

Presentation TCT 2021

Case 4: Red Light TMVr – MAC With MS/MR

Presenter: Leora Yarboro

November 06, 2021

Presentation TCT 2021

Case 3: Yellow Light TMVr – Barlow’s Valve With Multiple Prolapsing Segments

Presenter: Vivian Ng

November 06, 2021

Advertisement

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Differing Advice for Infective Endocarditis Surgery Stems From Evidence Gaps

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

Recent Advances in Transcatheter Tricuspid & Mitral Valve Replacement

Echocardiography to Assess & Facilitate Management of MR

Cardiologist Tests Positive for Omicron COVID-19 After Trip to PCR London Valves

December 2021 News Roundup

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI

Promising Early Results for TriClip in Tricuspid Regurgitation: bRIGHT Registry

PALACS: Posterior Left Pericardiotomy Cuts Postop AF After Cardiac Surgery

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

EXPAND G4: Core Laboratory Echocardiographic Outcomes From a Multicenter Study of a Fourth Generation TEER System to Treat Mitral Regurgitation

Expanding Treatable Anatomies with TMVR

Intrepid TA Data Review and Program Update

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

Intrepid TMVR Early Feasibility: Thirty-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement

Case 4: Red Light TMVr – MAC With MS/MR

Case 3: Yellow Light TMVr – Barlow’s Valve With Multiple Prolapsing Segments

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content